ask="1.97"
ask_size="10000"
average_daily_volume="440967"
bid="1.90"
bid_size="2400"
book_value="1.72"
change="-0.08"
change_from_200_day_moving_average="-0.56"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-4.10"
change_From_52_week_low="1.59"
change_in_percent="-4.10%"
close="1.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.25"
ebitda="-3.16M"
eps_estimate_current_year="-1.75"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="7629000"
high="1.98"
high_52_weeks="5.97"
last_trade_date="3/17/2017"
last_trade_price="1.87"
last_trade_size="97437"
last_trade_time="4:00pm"
low="1.87"
low_52_weeks="0.28"
market_capitalization="28.78M"
moving_average_200_day="2.43"
moving_average_50_day="2.06"
name="Eleven Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="12.00"
open="1.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.13%"
percent_change_from_50_day_moving_average="-9.02%"
percent_change_from_52_week_high="-68.68%"
percent_change_from_52_week_low="+560.78%"
previous_close="1.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.14"
price_per_sales="1.01"
revenue="29.72M"
shares_outstanding="15393000"
short_ratio="5.38"
stock_exchange="NGM"
symbol="EBIO"
volume="281828"
weeks_range_52="0.28 - 5.97"
